European Union pharmaceutical legislation
E130557
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
All labels observed (5)
How this entity was disambiguated
This entity first appeared as the object of triple T1143208 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: European Union pharmaceutical legislation Context triple: [European Medicines Agency, legalBasis, European Union pharmaceutical legislation]
-
A.
European Union medical device regulations
European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: European Union pharmaceutical legislation Target entity description: European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
A.
European Union medical device regulations
European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf |
European Union law
ⓘ
pharmaceutical law framework ⓘ regulatory framework ⓘ |
| aimsTo |
ensure a high level of protection of public health
ⓘ
ensure the free movement of medicinal products within the internal market ⓘ harmonise national rules on medicinal products ⓘ |
| appliesIn |
European Economic Area
ⓘ
European Union Member States ⓘ
linked to:
Member States of the European Union
|
| basedOn | Treaty on the Functioning of the European Union ⓘ |
| coordinatedBy | European Commission Directorate‑General for Health and Food Safety ⓘ |
| covers |
advanced therapy medicinal products
ⓘ
human medicinal products ⓘ orphan medicinal products ⓘ paediatric medicinal products ⓘ veterinary medicinal products ⓘ |
| defines |
obligations of manufacturers of medicinal products
ⓘ
obligations of marketing authorisation holders ⓘ obligations of wholesale distributors of medicinal products ⓘ requirements for clinical trials of medicinal products ⓘ requirements for labelling and package leaflets of medicines ⓘ requirements for marketing authorisation applications ⓘ rules for advertising of medicinal products ⓘ rules for pharmacovigilance reporting and signal detection ⓘ |
| establishes |
centralised marketing authorisation procedure
ⓘ
decentralised procedure for marketing authorisation ⓘ mutual recognition procedure for marketing authorisation ⓘ national marketing authorisation procedures ⓘ |
| governs |
authorization of medicinal products for human use in the EU
ⓘ
authorization of veterinary medicinal products in the EU ⓘ pharmacovigilance of medicinal products in the EU ⓘ quality of medicinal products in the EU ⓘ safety of medicinal products in the EU ⓘ supervision of medicinal products in the EU internal market ⓘ |
| implementedBy |
European Medicines Agency
ⓘ
national competent authorities of EU Member States ⓘ |
| includes |
Directive 2001/82/EC
ⓘ
Directive 2001/83/EC ⓘ Regulation (EC) No 1394/2007 ⓘ Regulation (EC) No 141/2000 ⓘ Regulation (EC) No 1901/2006 ⓘ Regulation (EC) No 726/2004 ⓘ Regulation (EU) 2019/6 ⓘ Regulation (EU) No 536/2014 ⓘ good distribution practice requirements for medicinal products ⓘ good manufacturing practice requirements for medicinal products ⓘ pharmacovigilance legislation package of 2010 ⓘ |
| legalBasis |
Article 114 TFEU
ⓘ
Article 168 TFEU ⓘ |
| monitoredBy |
Pharmacovigilance Risk Assessment Committee of the European Medicines Agency
ⓘ
linked to:
Pharmacovigilance Risk Assessment Committee
|
| subjectTo | ordinary legislative procedure of the European Union ⓘ |
| updatedBy | legislative proposals of the European Commission ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: European Union pharmaceutical legislation Description of subject: European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
Referenced by (6)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject linked to:
EMA
Regulation (EC) No 141/2000 on orphan medicinal products
→
relatedTo
→
EU pharmaceutical legislation
ⓘ
linked to: European Union pharmaceutical legislation
linked to: European Union pharmaceutical legislation
linked to: European Union pharmaceutical legislation
subject linked to:
Regulation (EC) No 1902/2006 amending Regulation (EC) No 1901/2006
linked to: European Union pharmaceutical legislation